The combination of AGTRAP and ALKBH3 had the strongest prognostic value for the OS of GBM patients (HR = 2.059, 95% CI = 1.343–3.157, p < 0.001; Table 4). This evidence concerns the gene ALKBH3 and glioblastoma.